ASVRX | ROFCX | ASVRX / ROFCX | |
Total Expense Ratio | 1.59 | 2.24 | 71% |
Annual Report Gross Expense Ratio | 1.59 | 2.34 | 68% |
Fund Existence | 15 years | 19 years | - |
Gain YTD | -5.128 | -11.308 | 45% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2000 | 125% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.82B | 996M | 484% |
Annual Yield % from dividends | 0.51 | 0.00 | - |
Returns for 1 year | -7.22 | -12.85 | 56% |
Returns for 3 years | -3.79 | -16.72 | 23% |
Returns for 5 years | 107.97 | 83.74 | 129% |
Returns for 10 years | 7.10 | -12.56 | -57% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVD | 38.62 | 5.13 | +15.32% |
GraniteShares 2x Short NVDA Daily ETF | |||
TAFI | 25.12 | 0.05 | +0.20% |
AB Tax-Aware Short Duration ETF | |||
FTXH | 26.59 | -0.42 | -1.55% |
First Trust Nasdaq Pharmaceuticals ETF | |||
SHE | 109.93 | -5.09 | -4.42% |
SPDR® MSCI USA Gender Diversity ETF | |||
IGM | 85.77 | -6.44 | -6.98% |
iShares Expanded Tech Sector ETF |